GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Glaxosmithkline Pharmaceuticals GLAXO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NSE stock exchange
operates under Pharmaceuticals sector
- IntraDay predictions, targets, What to do GLAXO
- Forcast & Targets GLAXO
- GLAXO Experts view
- Tomorrow's Movement GLAXO
- Technical Analysis Reports
- All in One Charts
- All indicators in One Charts
- GLAXO History
- Money flow charts
- Weekly charts
- Monthly charts
- Moving averages charts
- MACD charts
- Force Index charts
- Stochastics charts
- PVM charts
- RSI and MRSI charts
- Renko charts
- Point and Figure charts
Daily price and charts and targets GlaxosmithklinePharmaceuticals
Strong intraday Stock price targets for GlaxosmithklinePharmaceuticals are 2325 and 2393.1
| Intraday Target 1 | 2310.3 |
| Intraday Target 2 | 2339.7 |
| Intraday Target 3 | 2378.4 |
| Intraday Target 4 | 2407.8 |
| Intraday Target 5 | 2446.5 |
Daily price and volume Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Tue 13 January 2026 | 2369.10 (-1.17%) | 2397.00 | 2349.00 - 2417.10 | 0.8929 times | Mon 12 January 2026 | 2397.10 (1.05%) | 2372.00 | 2337.60 - 2403.80 | 0.6776 times | Fri 09 January 2026 | 2372.10 (-1.11%) | 2390.00 | 2350.00 - 2404.00 | 1.2404 times | Thu 08 January 2026 | 2398.70 (-2.48%) | 2455.00 | 2386.80 - 2455.30 | 0.6692 times | Wed 07 January 2026 | 2459.80 (-0.95%) | 2483.30 | 2448.00 - 2528.00 | 2.3729 times | Tue 06 January 2026 | 2483.30 (1.1%) | 2456.00 | 2437.20 - 2504.00 | 0.6952 times | Mon 05 January 2026 | 2456.20 (-1.11%) | 2484.90 | 2452.00 - 2484.90 | 0.6734 times | Fri 02 January 2026 | 2483.80 (1.14%) | 2461.30 | 2443.90 - 2487.70 | 0.4185 times | Thu 01 January 2026 | 2455.90 (-0.72%) | 2476.00 | 2442.50 - 2476.00 | 0.6214 times | Wed 31 December 2025 | 2473.60 (3.75%) | 2419.40 | 2382.00 - 2482.50 | 1.7386 times | Tue 30 December 2025 | 2384.20 (-3.76%) | 2462.20 | 2362.60 - 2468.40 | 7.8835 times |
Weekly price and charts GlaxosmithklinePharmaceuticals
Strong weekly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2313.6 and 2393.1
| Weekly Target 1 | 2295.1 |
| Weekly Target 2 | 2332.1 |
| Weekly Target 3 | 2374.6 |
| Weekly Target 4 | 2411.6 |
| Weekly Target 5 | 2454.1 |
Weekly price and volumes for Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Tue 13 January 2026 | 2369.10 (-0.13%) | 2372.00 | 2337.60 - 2417.10 | 0.2481 times | Fri 09 January 2026 | 2372.10 (-4.5%) | 2484.90 | 2350.00 - 2528.00 | 0.8926 times | Fri 02 January 2026 | 2483.80 (0.79%) | 2483.00 | 2362.60 - 2487.70 | 1.8072 times | Fri 26 December 2025 | 2464.30 (-2.56%) | 2530.10 | 2459.50 - 2550.10 | 0.4293 times | Fri 19 December 2025 | 2529.00 (-2.76%) | 2587.70 | 2506.70 - 2608.90 | 0.7881 times | Fri 12 December 2025 | 2600.80 (2.17%) | 2545.60 | 2491.00 - 2635.00 | 1.2334 times | Fri 05 December 2025 | 2545.60 (-0.93%) | 2551.00 | 2461.10 - 2582.50 | 1.2781 times | Fri 28 November 2025 | 2569.50 (2.87%) | 2497.90 | 2404.20 - 2585.10 | 1.0338 times | Fri 21 November 2025 | 2497.90 (0.75%) | 2491.70 | 2471.40 - 2532.60 | 0.9629 times | Fri 14 November 2025 | 2479.40 (-4.19%) | 2587.00 | 2467.50 - 2590.60 | 1.3265 times | Fri 07 November 2025 | 2587.90 (-1.17%) | 2644.00 | 2479.00 - 2694.00 | 1.1572 times |
Monthly price and charts GlaxosmithklinePharmaceuticals
Strong monthly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2258.15 and 2448.55
| Monthly Target 1 | 2221.17 |
| Monthly Target 2 | 2295.13 |
| Monthly Target 3 | 2411.5666666667 |
| Monthly Target 4 | 2485.53 |
| Monthly Target 5 | 2601.97 |
Monthly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Tue 13 January 2026 | 2369.10 (-4.22%) | 2476.00 | 2337.60 - 2528.00 | 0.2123 times | Wed 31 December 2025 | 2473.60 (-3.73%) | 2551.00 | 2362.60 - 2635.00 | 0.8741 times | Fri 28 November 2025 | 2569.50 (-1.88%) | 2644.00 | 2404.20 - 2694.00 | 0.7291 times | Fri 31 October 2025 | 2618.60 (-1.55%) | 2659.70 | 2601.00 - 2795.90 | 0.4734 times | Tue 30 September 2025 | 2659.70 (-4.5%) | 2786.00 | 2622.60 - 2883.40 | 0.7542 times | Fri 29 August 2025 | 2785.00 (-11.94%) | 3162.90 | 2560.00 - 3184.30 | 1.0437 times | Thu 31 July 2025 | 3162.60 (-6.66%) | 3388.70 | 3072.50 - 3450.00 | 0.6372 times | Mon 30 June 2025 | 3388.10 (2.71%) | 3298.00 | 3153.90 - 3515.70 | 1.2749 times | Fri 30 May 2025 | 3298.60 (11.27%) | 2935.30 | 2693.90 - 3398.00 | 2.2895 times | Wed 30 April 2025 | 2964.60 (2.92%) | 2872.00 | 2401.00 - 3148.00 | 1.7116 times | Fri 28 March 2025 | 2880.35 (16.36%) | 2485.00 | 2390.05 - 2988.00 | 1.1903 times |
Yearly price and charts GlaxosmithklinePharmaceuticals
Strong yearly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2258.15 and 2448.55
| Yearly Target 1 | 2221.17 |
| Yearly Target 2 | 2295.13 |
| Yearly Target 3 | 2411.5666666667 |
| Yearly Target 4 | 2485.53 |
| Yearly Target 5 | 2601.97 |
Yearly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Tue 13 January 2026 | 2369.10 (-4.22%) | 2476.00 | 2337.60 - 2528.00 | 0.0311 times | Wed 31 December 2025 | 2473.60 (9.85%) | 2235.00 | 1921.00 - 3515.70 | 2.7049 times | Tue 31 December 2024 | 2251.85 (18.63%) | 1905.90 | 1842.05 - 3088.00 | 2.2997 times | Fri 29 December 2023 | 1898.15 (43.94%) | 1300.00 | 1227.00 - 1959.00 | 1.2784 times | Fri 30 December 2022 | 1318.75 (-24.93%) | 1763.00 | 1295.95 - 1789.90 | 0.7425 times | Fri 31 December 2021 | 1756.65 (8.17%) | 1607.20 | 1376.00 - 1918.75 | 0.9904 times | Thu 31 December 2020 | 1623.95 (0.85%) | 1626.00 | 962.65 - 1807.50 | 1.1053 times | Tue 31 December 2019 | 1610.30 (6.27%) | 1500.35 | 1130.00 - 1737.00 | 0.4728 times | Mon 31 December 2018 | 1515.35 (-39.13%) | 2490.00 | 1251.00 - 3600.00 | 0.2405 times | Fri 29 December 2017 | 2489.30 (-8.81%) | 2725.00 | 2201.20 - 2798.50 | 0.1345 times | Fri 30 December 2016 | 2729.80 (-17.15%) | 3277.00 | 2600.00 - 3872.00 | 0.1348 times |
Indicator Analysis of GlaxosmithklinePharmaceuticals
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be in downtrend.
But this trend seems to be weakening.Price is below an important level of 2432.35 on charts, and if price remains below this level, then stock might show a fall in short term.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO made a big move recently. This generally happens when there is a positive sentiment change, or a block deal went through. There is a good chance that this trend might continue in coming days.
Munafa value: 45 as on Tue 13 January 2026
This Munafa value indicates that the stock is moving sideways and there is no definite momentum in the stock.
SMA20 is at 2472 and price is deviating by 63 points
Upper Bollinger band is at 2598 and lower is at 2347, while middle bands are at 2409 and 2535
Price is coming down
Price is below 20day SMA
Price is in lower range of bands
Price action analysis of GlaxosmithklinePharmaceuticals (GLAXO) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for GlaxosmithklinePharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for GlaxosmithklinePharmaceuticals in short term and the sell signal is strong.
GlaxosmithklinePharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for GlaxosmithklinePharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of GlaxosmithklinePharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2437.04 and GlaxosmithklinePharmaceuticals GLAXO stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the GlaxosmithklinePharmaceuticals GLAXO stock. Volume based technical analysis of GlaxosmithklinePharmaceuticals GLAXO stock is negative.
GlaxosmithklinePharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
DMA SMA EMA moving averages of Glaxosmithkline Pharmaceuticals GLAXO
DMA (daily moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| DMA period | DMA value |
| 5 day DMA | 2399.36 |
| 12 day DMA | 2434.27 |
| 20 day DMA | 2471.87 |
| 35 day DMA | 2502.57 |
| 50 day DMA | 2512.1 |
| 100 day DMA | 2630.43 |
| 150 day DMA | 2795.73 |
| 200 day DMA | 2830.72 |
EMA (exponential moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| EMA period | EMA current | EMA prev | EMA prev2 |
| 5 day EMA | 2398.01 | 2412.46 | 2420.14 |
| 12 day EMA | 2432.35 | 2443.85 | 2452.35 |
| 20 day EMA | 2458.41 | 2467.81 | 2475.25 |
| 35 day EMA | 2486.19 | 2493.08 | 2498.73 |
| 50 day EMA | 2511.57 | 2517.38 | 2522.29 |
SMA (simple moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| SMA period | SMA current | SMA prev | SMA prev2 |
| 5 day SMA | 2399.36 | 2422.2 | 2434.02 |
| 12 day SMA | 2434.27 | 2442.2 | 2449.68 |
| 20 day SMA | 2471.87 | 2482.32 | 2492.5 |
| 35 day SMA | 2502.57 | 2505.65 | 2508.53 |
| 50 day SMA | 2512.1 | 2517.09 | 2521.59 |
| 100 day SMA | 2630.43 | 2634.81 | 2638.78 |
| 150 day SMA | 2795.73 | 2802.59 | 2809.53 |
| 200 day SMA | 2830.72 | 2833.29 | 2835.98 |
Fundamentals, profit and EPS of Glaxosmithkline Pharmaceuticals GLAXO
EPS is 56.39 and PE is: 42.01
Last quarter profit: (September 2025 quarter) 257.49 crores (2.57%)
Debt: 35.71 in crores
Market capitalization: 43709.18
EPS is 56.09 and PE is: 42.24
Last quarter profit: (June 2025 quarter) 205.01 crores (12.44%)
Debt: 9.95 in crores
Market capitalization: 47197.61
Videos related to: GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance


